nor -MC3 and nor -KC2: cationic ionizable lipids for the delivery of therapeutic nucleic acids
RSC Pharmaceutics · 2026 · 3 (3) · 654-658
DOI: 10.1039/d5pm00350d ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Deaglan Arnold und 11 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Mitacs.
Abstract (Originalsprache)
Analogues of MC3 and KC2 wherein C 17 lipophilic chains are present in lieu of C 18 ones exhibit favorable in vivo delivery relative to the originals and are easier and more economical to synthesize.
Förderung
- Mitacs
Zitieren
APA
Arnold, D., Atmuri, N. D. P., Saadati, F., Nabi, A., Kurek, D. Z., Tam, A., Adak, T., Witzigmann, D., Sammis, G., Cullis, P. R., Kulkarni, J., & Ciufolini, M. A. (2026). nor -MC3 and nor -KC2: cationic ionizable lipids for the delivery of therapeutic nucleic acids. RSC Pharmaceutics, 3(3), 654-658. https://doi.org/10.1039/d5pm00350d
Vancouver
Arnold D, Atmuri NDP, Saadati F, Nabi A, Kurek DZ, Tam A, et al. nor -MC3 and nor -KC2: cationic ionizable lipids for the delivery of therapeutic nucleic acids. RSC Pharmaceutics. 2026;3(3):654-658. doi:10.1039/d5pm00350d
BibTeX
@article{Arnold2026,
author = {Arnold, Deaglan and Atmuri, Nagavenkata Durga Prasad and Saadati, Fariba and Nabi, Ardalan and Kurek, Daniel Z. and Tam, Anthony and Adak, Taniya and Witzigmann, Dominik and Sammis, Glenn and Cullis, Pieter R. and Kulkarni, Jayesh and Ciufolini, Marco A.},
title = {nor -MC3 and nor -KC2: cationic ionizable lipids for the delivery of therapeutic nucleic acids},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {3},
pages = {654--658},
doi = {10.1039/d5pm00350d}
}
EUVIMED